title: Treatment of Hepatic Adenomatosis.
abstract: Hepatic adenomatosis and hepatocellular adenomas share risk factors and the same pathophysiologic spectrum. The presence in the liver of 10 hepatocellular adenomas defines hepatic adenomatosis. The diagnosis may be established incidentally during a liver radiologic examination in the asymptomatic patient, or after associated right upper quadrant pain, hepatomegaly or liver test abnormalities. Upon the diagnosis of hepatic adenomatosis or either of its life-threatening complications - hemorrhage and progression to hepatocellular carcinoma - consideration should be given to potential medical, radiologic and surgical interventions including: observation (estrogens and androgens withdrawal), resection, transarterial embolization, radiofrequency ablation and liver transplantation. The management of patients with hepatic adenomatosis can be challenging. These patients should be ideally referred to centers with expertise in the management of liver diseases.
authors.affiliation: Dr. Claire Meyer, cmeyer@dom.wustl.edu , Fellow in Gastroenterology, Division of Gastroenterology, Washington University School of Medicine, South Euclid Ave, Box 8124, St. Louis, MO, 63110, Tel 314 454 8141.
authors.forename: Claire
authors.initials: C
authors.lastname: Meyer
authors.affiliation: Dr. Mauricio Lisker-Melman, mlisker@dom.wustl.edu , Professor of Medicine, Director Hepatology Program, Division of Gastroenterology, Washington University School of Medicine, 660 South Euclid Ave, Box 8124, St. Louis, MO, 63110, Tel 314 454 8141.
authors.forename: Mauricio
authors.initials: M
authors.lastname: Lisker-Melman
keywords: Hepatic adenomatosis; liver adenomatosis; management of liver adenomatosis; treatment of hepatic adenomatosis